A comprehensive view of Gerresheimer AG. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Gerresheimer partners with medtech start-up Adamant Health to develop measuring technology and digital platform to determine optimal time to take Parkinson’s Disease symptom-suppressing medication; disease affects about 10 million patients worldwide
Published:
June 14, 2022
by Gerresheimer
|
Gerresheimer signs agreement with drug development firm ISR for large-scale production of IcoOne nasal inhaler for ISR’s Phase 3 study of its dry powder COVID-19 vaccine; Gerresheimer has annual production capacity of more than 100 million inhalers
Published:
June 02, 2022
by Gerresheimer AG
|
Gerresheimer highlights its container-level traceability from production to point-of-care; company applies unique codes to primary packaging and medical devices, allowing downstream parties to link, analyze, share data with the individual product unit
Published:
May 25, 2022
by Gerresheimer AG
|
Gerresheimer ramps up pharmaceutical glass and plastic production capacities in India; a new plant for plastic containers and closures is now up at its Kosamba site, and glass production received new state-of-the-art and sustainable furnace technology
Published:
May 16, 2022
by Gerresheimer AG
|
Drug delivery systems firm Gerresheimer invests in Portal Instruments to develop needle-free drug delivery platform for biologics, biosimilars; Portal offers needle-free injector, cartridge that injects in under a second and adherence tracking technology
Published:
May 10, 2022
by Gerresheimer AG
|
Ask us about our Health Care Sector market view
Trending Chart
Interactive chart with headline count